Alexion Pharmaceuticals Inc. (ALXN) Slipped -8.82% or -12.08 To Price $124.86 On Wednesday

Alexion Pharmaceuticals Inc. (ALXN) slipped -8.82% or -12.08 to $124.86. It is nearly 2.12 million shares traded, which is 161.07% compare to the average total volume 1.32 million. The market cap of ALXN is $28.01 billion. The year to date change is 30.84%. The 52 week price range is from $92.56 to $141.86. Price of ALXN have changed -3.09% during last week. It have changed 2.57% over last month, 22.60% over last 3 months, 7.24% over last 6 months and 25.08% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALXN is 132.56. It is 6.17% above current price. The 200-day Moving Averages for ALXN is 123.75. It is -0.89% below current price. The stock is at support level of 200-day moving averages. The 52-week High is 141.86. It is 13.62% from the current price. The 52-week Low is 92.56. It is -25.87% from current price.

There are some statistics of ALXN. It is has market cap $28.01 billion. The share outstanding is 224.30 million. The average volume is 1.32 million. The percent of top 15 Institution holding is 161.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALXN is 0.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALXN is 0.58%.


Share this post